CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 907 shares at an average $0.55 ($503)
- 4 Open-market sale Chief Medical Officer sold 2,350 shares at $0.54 ($1,269)
- 4 Grant or award Chief Financial Officer acquired 19,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- F-6 POS Other F-6 POS
- 8-K Event Shareholder rights changed · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 4 Open-market sale Chief Medical Officer sold 1,785 shares at $0.98 ($1,749)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Delisting notice
Page 6 of 29 · 577 filings